MYX mayne pharma group limited

doi: 10.1080/13625187.2017.1336532Their new oral contraceptive...

  1. 83 Posts.
    lightbulb Created with Sketch. 33
    doi: 10.1080/13625187.2017.1336532
    Their new oral contraceptive Nextstellis passed Phase 3 trials and now before FDA for final approval. It is the first oral contraceptive with a natural estrogen (present in fetal liver) to be available in 5 years. Studies show women who take is have less weight gain (this is going to be a decider).

    https://doi.org/10.1080/13625187.2017.1336532

    if approved, will be very strong news.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.13 $5.15 $5.08 $445.2K 87.01K

Buyers (Bids)

No. Vol. Price($)
1 810 $5.08
 

Sellers (Offers)

Price($) Vol. No.
$5.15 2033 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.